Meeder Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $34.7M | Sell |
28,922
-997
| -3% | -$1.02M | 1.77% | 10 |
|
|
2026
Q1 | $27.5M | Buy |
29,919
+1,672
| +6% | +$1.7M | 1.58% | 12 |
|
|
2025
Q4 | $30.4M | Buy |
28,247
+10,919
| +63% | +$10.4M | 1.64% | 13 |
|
|
2025
Q3 | $13.2M | Sell |
17,328
-3,902
| -18% | -$2.9M | 0.75% | 35 |
|
|
2025
Q2 | $16.5M | Sell |
21,230
-2,004
| -9% | -$1.56M | 1.02% | 21 |
|
|
2025
Q1 | $19.2M | Sell |
23,234
-8,058
| -26% | -$6.7M | 1.29% | 15 |
|
|
2024
Q4 | $24.2M | Sell |
31,292
-6,295
| -17% | -$5.21M | 1.68% | 14 |
|
|
2024
Q3 | $33.3M | Buy |
37,587
+5,167
| +16% | +$4.65M | 2.22% | 11 |
|
|
2024
Q2 | $29.4M | Buy |
32,420
+8,355
| +35% | +$6.68M | 2.06% | 13 |
|
|
2024
Q1 | $18.7M | Buy |
24,065
+14,909
| +163% | +$10.6M | 1.18% | 21 |
|
|
2023
Q4 | $5.34M | Sell |
9,156
-16,135
| -64% | -$9.42M | 0.42% | 59 |
|
|
2023
Q3 | $13.6M | Sell |
25,291
-3,789
| -13% | -$1.95M | 1.07% | 24 |
|
|
2023
Q2 | $13.6M | Buy |
29,080
+15,265
| +110% | +$6.4M | 0.99% | 20 |
|
|
2023
Q1 | $4.74M | Sell |
13,815
-16,191
| -54% | -$5.46M | 0.38% | 64 |
|
|
2022
Q4 | $11M | Sell |
30,006
-8,833
| -23% | -$3.13M | 0.96% | 18 |
|
|
2022
Q3 | $12.6M | Buy |
38,839
+37
| +0.1% | +$11.7K | 0.72% | 29 |
|
|
2022
Q2 | $12.6M | Buy |
38,802
+4,010
| +12% | +$1.2M | 0.73% | 25 |
|
|
2022
Q1 | $9.96M | Buy |
34,792
+9,390
| +37% | +$2.42M | 0.49% | 46 |
|
|
2021
Q4 | $7.02M | Sell |
25,402
-9,494
| -27% | -$2.41M | 0.71% | 29 |
|
|
2021
Q3 | $8.06M | Sell |
34,896
-1,628
| -4% | -$402K | 0.42% | 60 |
|
|
2021
Q2 | $8.38M | Sell |
36,524
-240
| -0.7% | -$48.2K | 0.39% | 60 |
|
|
2021
Q1 | $6.87M | Buy |
36,764
+32,524
| +767% | +$6.36M | 0.35% | 61 |
|
|
2020
Q4 | $716K | Sell |
4,240
-43,959
| -91% | -$6.56M | 0.16% | 117 |
|
|
2020
Q3 | $7.13M | Sell |
48,199
-12,299
| -20% | -$1.9M | 0.46% | 47 |
|
|
2020
Q2 | $9.93M | Sell |
60,498
-5,952
| -9% | -$914K | 0.65% | 36 |
|
|
2020
Q1 | $9.22M | Sell |
66,450
-11,916
| -15% | -$1.64M | 0.72% | 24 |
|
|
2019
Q4 | $10.3M | Buy |
78,366
+3,825
| +5% | +$443K | 0.63% | 39 |
|
|
2019
Q3 | $8.34M | Buy |
74,541
+171
| +0.2% | +$19K | 0.55% | 57 |
|
|
2019
Q2 | $8.24M | Buy |
74,370
+22,887
| +44% | +$2.7M | 0.57% | 53 |
|
|
2019
Q1 | $6.68M | Buy |
51,483
+5,128
| +11% | +$624K | 0.53% | 57 |
|
|
2018
Q4 | $5.36M | Buy |
46,355
+22,631
| +95% | +$2.53M | 0.48% | 60 |
|
|
2018
Q3 | $2.55M | Buy |
23,724
+15,442
| +186% | +$1.54M | 0.19% | 118 |
|
|
2018
Q2 | $707K | Buy |
8,282
+4,931
| +147% | +$405K | 0.06% | 310 |
|
|
2018
Q1 | $259K | Buy |
3,351
+611
| +22% | +$49.2K | 0.02% | 419 |
|
|
2017
Q4 | $231K | Buy |
2,740
+680
| +33% | +$57.9K | 0.02% | 447 |
|
|
2017
Q3 | $176K | Buy |
2,060
+503
| +32% | +$41.3K | 0.02% | 488 |
|
|
2017
Q2 | $128K | Sell |
1,557
-1,869
| -55% | -$152K | 0.01% | 524 |
|
|
2017
Q1 | $288K | Buy |
+3,426
| New | +$274K | 0.03% | 460 |
|
|
2016
Q4 | – | Sell |
-21,429
| Closed | -$1.72M | – | 1015 |
|
|
2016
Q3 | $1.72M | Sell |
21,429
-10,864
| -34% | -$870K | 0.15% | 157 |
|
|
2016
Q2 | $2.54M | Sell |
32,293
-2,328
| -7% | -$175K | 0.24% | 91 |
|
|
2016
Q1 | $2.49M | Buy |
34,621
+3,215
| +10% | +$243K | 0.23% | 97 |
|
|
2015
Q4 | $2.65M | Buy |
31,406
+11,017
| +54% | +$914K | 0.24% | 117 |
|
|
2015
Q3 | $1.71M | Buy |
+20,389
| New | +$1.72M | 0.17% | 148 |
|
|
2015
Q2 | – | Sell |
-8,430
| Closed | -$612K | – | 503 |
|
|
2015
Q1 | $612K | Hold |
8,430
| – | – | 0.07% | 331 |
|
|
2014
Q4 | $582K | Buy |
+8,430
| New | +$569K | 0.07% | 288 |
|
|
2013
Q3 | – | Sell |
-95,870
| Closed | -$4.71M | – | 368 |
|
|
2013
Q2 | $4.71M | Buy |
+95,870
| New | +$5.22M | 0.93% | 34 |
|
Other funds holding LLY
Meeder Asset Management's LLY Position: Q2 2026 in Review
Meeder Asset Management reduced its Eli Lilly (LLY) stake by 3.3% in Q2 2026, selling an estimated $1.02M and leaving 28,922 shares worth $34.7M. The position accounts for 1.77% of the portfolio, ranked #10.
Meeder Asset Management first reported a position in LLY in Q2 2013 and has held it in 46 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Meeder Asset Management held 28,922 shares of Eli Lilly worth $34.7M as of Q2 2026.
- Meeder Asset Management sold 997 Eli Lilly shares in Q2 2026, an estimated $1.02M.
- Eli Lilly made up 1.77% of Meeder Asset Management's portfolio in Q2 2026, its #10 holding.
- Meeder Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 46 quarters since.
- 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Meeder Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.